Brainsway Ltd
BRSYF
Market Cap$294.11M
Close$
$-1695.70
30987.1% downside
Current Fair Value
30987.1% downsideOvervalued by 30987.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $294.11 Million |
|---|---|
| Enterprise Value | $249.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.09 |
| Beta | 0.33 |
| Outstanding Shares | 40,540,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 57.7 |
|---|---|
| PEG | 24.26 |
| Price to Sales | 5.49 |
| Price to Book Ratio | 5.49 |
| Enterprise Value to Revenue | 5.41 |
| Enterprise Value to EBIT | 38.23 |
| Enterprise Value to Net Income | 46 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Brainsway Ltd.
CEO: Christopher von Jako Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the tr...